Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TandemAI
AddedFeb 17, 2024
UpdatedJun 18, 2026
TandemAI

TandemAI

Series A

TandemAI: An advanced AI company revolutionizing drug discovery.

HQ
New York City, NY, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

TandemAI was founded with the mission to revolutionize the drug discovery process through advanced artificial intelligence and physics-based platforms. The company aims to integrate innovative technologies into traditional workflows, thereby accelerating the discovery and development of new drugs. Their flagship product, TandemViz, empowers research teams by providing a comprehensive, integrated platform for drug discovery. TandemAI focuses on leveraging AI to streamline and enhance the efficiency of pharmaceutical research and development.

Notable figures affiliated with TandemAI include leading experts in AI and drug discovery, though specific names are not publicly highlighted. The company has garnered attention through significant media coverage and industry events, such as webinars on AI and computational tools. TandemAI's key achievements include the successful integration of their AI platform into existing drug discovery processes, significantly reducing time and costs associated with bringing new drugs to market. Their impact is marked by a transformative approach that promises to redefine the future of pharmaceutical research.

TandemAI - Similar Companies

Zephyr AI logo

Zephyr AI

zephyrai.bio

DeepCure logo

DeepCure

deepcure.ai

Phronesis Artificial Intelligence logo

Phronesis Artificial Intelligence

phronesisai.com

Terray Therapeutics logo

Terray Therapeutics

terraytx.com

Cognaisent logo

Cognaisent

cognaisent.com

Biosim logo

Biosim

Numerion Labs logo

Numerion Labs

numerionlabs.ai

AMPLY Discovery logo

AMPLY Discovery

amplydiscovery.com

Iambic Therapeutics logo

Iambic Therapeutics

iambic.ai

Atommap logo

Atommap

Pathos AI logo

Pathos AI

pathos.com

Turing Labs Inc. logo

Turing Labs Inc.

turingsaas.com

Atomic AI logo

Atomic AI

atomic.ai

Harmonic Discovery logo

Harmonic Discovery

Cedience logo

Cedience

cedience.com

TandemAI - Quick Facts

Who are TandemAI's competitors?

Companies similar to TandemAI include Zephyr AI, DeepCure, Phronesis Artificial Intelligence and Terray Therapeutics.

When was TandemAI founded?

TandemAI was founded in 2021.

Where is TandemAI's headquarters located?

TandemAI's headquarters is located in New York City, NY, US.

When was TandemAI's last funding round?

TandemAI's most recent funding round was for $35M (USD) in March 2023.

How much has TandemAI raised to-date?

As of Mar 1, 2023, TandemAI has raised a total of $60M (USD).

How many employees does TandemAI have?

TandemAI has 46 employees as of Feb 4, 2024.

TandemAI - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified